HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

878.521

-11.888-1.34%

Number of Gainers:4

Number of Losers:13

Number of Flat:- -

PE:- -

High:889.460

Open:889.460

Low:870.070

Close:890.408

Volume:228.24M

Turnover:1.69B

Market Cap:593.18B

Float Cap:491.90B

Loading ...

Sino Biopharma Licenses HER2 ADC Tqb2102 to Cipla for India, South Africa, Other Emerging Markets in Deal Worth up to USD 123 Million

Sino Biopharmaceutical - Cipla Granted Exclusive License for Tqb2102 in India, South Africa and Five Markets

THOMSON REUTERS

Sino Biopharmaceutical - Group Eligible for up to $123 Mln in Milestone Payments and Tiered Double-Digit Royalties

THOMSON REUTERS

Jefferies Adjusts BYD Electronic (International)'s Price Target to HK$25 From HK$29, Keeps at Hold

MT Newswires Live

Cipla and SBP Group Sign Exclusive Licensing Agreement for HER2 Bispecific Antibody-Drug Conjugate

China's AustAsia Swings to Profit in H1, Aided by Lower Feed Costs and Higher Beef Prices

Hong Kong's Lee's Pharmaceutical H1 Profit Jumps on Higher-Margin Product Sales

Veson Holdings Returns to Profit as Power Bank Sales Surge

China's HeartCare Medical H1 Revenue Surges on Stroke Segment Growth

Sinopharm Group Announces Extraordinary General Meeting

Sinopharm Proposes Re-Electing Jin Bin as Chairman for Seventh Board Term

Sinopharm Group Stock Slides 2.7% in Hong Kong

Sino Biopharmaceutical Stock Sheds 2.6% in Hong Kong

CSPC Pharmaceutical Group Stock Sheds 3.0% in Hong Kong, Underperforms Competitors

BYD Electronic (International) Stock Rises 9.0% in Hong Kong

AH Share Premium Report: August 31 Market Close

Ascletis Pharma Starts Phase III Trial of Weight-Loss Drug; Shares Plummet 5%

MT Newswires Live

CanSino Leads HK-Listed Vaccine Makers Lower as BioNTech Halts mRNA Trial

Ascletis Announces First Participant Dosed in a Global Phase Iii Clinical Program of Once-Daily Oral Small Molecule Glp-1 Receptor Agonist Asc30 for Chronic Weight Management

THOMSON REUTERS

Ascletis Pharma - Topline Phase Iii Data Expected Q3 2028; FDA Nda by End 2028; Ema Maa Early 2029

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/BK1515/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":878.5206,"timestamp":1789111867791,"preClose":890.4082,"halted":0,"volume":228239017,"delay":0,"changeRate":-0.013351,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-11.887573,"latestTime":"09-11 15:31:08","open":889.45984,"high":889.45984,"low":870.06995,"amount":1693300421,"amplitude":0.021776,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789114200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"pbRate":1.335759,"peRate":17.310205,"turnoverRate":0.003126,"increases":4,"decrements":13,"flats":0,"marketCap":593179145280,"floatMarketCap":491897154112},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":889.45984,"amplitude":0.021776,"preClose":890.4082,"low":870.06995,"pbRate":"1.335759","latestPrice":878.5206,"volume":228239017,"delay":0,"open":889.45984,"prevYearClose":1190.107,"prevWeekClose":936.431,"prevMonthClose":925.265,"prevQuarterClose":802.777,"fiveDayClose":936.431,"twentyDayClose":912.416,"sixtyDayClose":852.523,"secType":"PLATE","market":"HK","turnoverRate":0.003126,"peRate":17.310205,"marketCap":593179145280,"floatMarketCap":491897154112,"timestamp":1789111867791,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":4,"down":13,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663843072","title":"Sino Biopharma Licenses HER2 ADC Tqb2102 to Cipla for India, South Africa, Other Emerging Markets in Deal Worth up to USD 123 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663843072","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663843072?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:40","pubTimestamp":1788172833,"startTime":"0","endTime":"0","summary":"Sino Biopharma licenses HER2 ADC TQB2102 to Cipla for India, South Africa, other emerging markets in deal worth up to USD 123 millionSino Biopharmaceutical unit Chia Tai Tianqing signed an exclusive l","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL8ylZt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YT58.USD","BK1521","01177","HK0000165453.HKD","IE00BZ08YR35.GBP","BK1191","BK1589","BK1515","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663074047","title":"Sino Biopharmaceutical - Cipla Granted Exclusive License for Tqb2102 in India, South Africa and Five Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2663074047","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663074047?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:39","pubTimestamp":1788172791,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R02R:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BZ08YT58.USD","BK1521","IE00BZ08YR35.GBP","BK1589","01177","BK1515","IE00BZ08YS42.EUR","BK1191","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663074024","title":"Sino Biopharmaceutical - Group Eligible for up to $123 Mln in Milestone Payments and Tiered Double-Digit Royalties","url":"https://stock-news.laohu8.com/highlight/detail?id=2663074024","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663074024?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:39","pubTimestamp":1788172791,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R02R:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1521","BK1515","HK0000165453.HKD","01177","IE00BZ08YS42.EUR","BK1191","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663639074","title":"Jefferies Adjusts BYD Electronic (International)'s Price Target to HK$25 From HK$29, Keeps at Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2663639074","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663639074?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:19","pubTimestamp":1788171577,"startTime":"0","endTime":"0","summary":"Jefferies Adjusts BYD Electronic (International)'s Price Target to HK$25 From HK$29, Keeps at Hold","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0274383008.USD","BK1504","LU0348767384.USD","BK1167","BK1580","00285","LU0348766576.USD","BK1589","BK1540","BK1582","BK1149","BK1515","BK1607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663107455","title":"Cipla and SBP Group Sign Exclusive Licensing Agreement for HER2 Bispecific Antibody-Drug Conjugate","url":"https://stock-news.laohu8.com/highlight/detail?id=2663107455","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663107455?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:16","pubTimestamp":1788171379,"startTime":"0","endTime":"0","summary":"BRIEF-Cipla and SBP Group Sign Exclusive Licensing Agreement For HER2 Bispecific Antibody-Drug ConjugateAug 31 (Reuters)-Cipla LtdCIPL.NS:CO AND SBP GROUP SIGN EXCLUSIVE LICENSING AGREEMENT FOR HER2 B","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0B5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YS42.EUR","01177","BK1589","HK0000165453.HKD","IE00BZ08YR35.GBP","BK1515","IE00BZ08YT58.USD","BK1191","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663074834","title":"China's AustAsia Swings to Profit in H1, Aided by Lower Feed Costs and Higher Beef Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2663074834","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663074834?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:10","pubTimestamp":1788171031,"startTime":"0","endTime":"0","summary":"China's AustAsia swings to profit in H1, aided by lower feed costs and higher beef pricesOverviewChina dairy and beef producer's revenue rose 1.6% yr/yr for six months ended JuneNet income attributabl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0B8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600085","BK1515","BK1606","BK1191","BK0086","LU1688375341.USD","BK1237","BK0012","01666","02425","BK0239","BK0028","BK0097","BK0113","BK0196","BK0183","BK1583","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663437071","title":"Hong Kong's Lee's Pharmaceutical H1 Profit Jumps on Higher-Margin Product Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2663437071","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663437071?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:00","pubTimestamp":1788170409,"startTime":"0","endTime":"0","summary":"Hong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product salesOverviewHong Kong pharma maker's interim revenue grew 14.6% yr/yr for six months ended June 2026Net income attributable t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0AP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","BK1583","BK1515","06622","01477","BK1587","00570","BK1191","BK1574","00950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663079376","title":"Veson Holdings Returns to Profit as Power Bank Sales Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2663079376","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663079376?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:32","pubTimestamp":1788168730,"startTime":"0","endTime":"0","summary":"Veson Holdings returns to profit as power bank sales surgeOverviewChina battery maker's interim revenue up 16%, returning to profit from prior-year lossGross margin fell to 6.5% from 7.5% due to produ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0A1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0633140727.USD","BK1116","LU1064131003.USD","LU2495084118.USD","LU2580892862.HKD","BK1515","BK0169","LU2663582299.SGD","LU1820825898.SGD","LU2328871848.SGD","BK0072","LU2289578879.USD","LU1580142542.USD","LU2148510915.USD","BK1149","LU0683595622.HKD","EVS.SI","LU1997245094.SGD","LU0633140560.USD","BK1167","LU1969619763.USD","01399","LU1781817850.SGD","BK1540","00285","BK0196","LU1861219969.SGD","BK1582","BK1504","BK1607","LU0274383008.USD","BK1589","LU1064130708.USD","BK0070","LU2360107325.USD","LU1146622755.USD","BK0014","LU1997245177.USD","002594","LU2580892789.USD","BK0264","BK0188","BK0183","LU1861214812.USD","LU1997244956.HKD","LU1508157978.USD","BK1580","LU0348766576.USD","BK0155","LU0348767384.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663928076","title":"China's HeartCare Medical H1 Revenue Surges on Stroke Segment Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2663928076","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663928076?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:14","pubTimestamp":1788167685,"startTime":"0","endTime":"0","summary":"China's HeartCare Medical H1 revenue surges on stroke segment growthOverviewChina medical device maker's H1 revenue rose 56.9% yr/yr to RMB291 mlnNet profit attributable to shareholders grew 18.5% yr/","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S09G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0097","BK1191","01477","600085","BK0028","BK1587","06609","BK0239","BK0183","BK0012","BK1606","06622","BK1100","01666","BK1574","BK0196","LU1688375341.USD","BK1515","BK0113","BK1583","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663076539","title":"Sinopharm Group Announces Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2663076539","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663076539?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:05","pubTimestamp":1788167143,"startTime":"0","endTime":"0","summary":"Sinopharm Group announces extraordinary general meetingSinopharm will hold an extraordinary general meeting in Shanghai on Sept. 15, 2026.Shareholders will vote on re-electing the board for its sevent","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL297pyQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1197","01099","LU1115378108.SGD","LU0640798160.USD","BK1515","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663075548","title":"Sinopharm Proposes Re-Electing Jin Bin as Chairman for Seventh Board Term","url":"https://stock-news.laohu8.com/highlight/detail?id=2663075548","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663075548?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:40","pubTimestamp":1788165611,"startTime":"0","endTime":"0","summary":"Sinopharm proposes re-electing Jin Bin as chairman for seventh board termSinopharm set an extraordinary general meeting for Sept. 15, 2026 to vote on re-electing directors for its seventh board term.E","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL71v6pd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099","LU0640798160.USD","SHTDY","BK1515","LU1115378108.SGD","BK1500","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663073083","title":"Sinopharm Group Stock Slides 2.7% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2663073083","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663073083?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:33","pubTimestamp":1788165180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. slid 2.7% to 15.50 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.1% to 25566.99.Sinopharm Group Co. Ltd. closed 31% short of its 52-week high of HK$22.34, which the company achieved Feb. 25.Despite its losses, the stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 3.1%.Trading volume totaled 8.7 million shares, compared to the 50-day average of 5.2 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1197","BK1500","LU0640798160.USD","01099","BK4175","SHTDY","BK1515","LU1115378108.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663073068","title":"Sino Biopharmaceutical Stock Sheds 2.6% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2663073068","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663073068?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:33","pubTimestamp":1788165180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slipped 2.6% to 5.45 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.1% to 25566.99.This was the stock's third consecutive day of losses.Sino Biopharmaceutical Ltd. closed 40% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 3.0% and Amgen Inc. remained unchanged.Trading volume totaled 92.9 million shares, compared to the 50-day average of 102.9 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YT58.USD","HK0000165453.HKD","BK1521","IE00BZ08YS42.EUR","BK1191","BK1589","IE00BZ08YR35.GBP","01177","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663073038","title":"CSPC Pharmaceutical Group Stock Sheds 3.0% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663073038","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663073038?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:32","pubTimestamp":1788165120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. slipped 3.0% to 9.24 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.1% to 25566.99.This was the stock's second consecutive day of losses.CSPC Pharmaceutical Group Ltd. closed 21% short of its 52-week high of HK$11.63, which the company reached Sept. 9.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. fell 2.6%, SSY Group Ltd. rose 0.4%, and United Laboratories International Holdings Ltd. fell 3.4%.Trading volume totaled 136.5 million shares, compared to the 50-day average of 104.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2039709279.SGD","LU1993786604.SGD","IE00B031HY20.USD","KURE","SG9999004220.SGD","HK0000165453.HKD","LU1328277881.USD","LU1960683339.HKD","IE00BZ08YT58.USD","LU1226287529.USD","LU1813983027.USD","LU1951186391.HKD","01093","LU1226288170.HKD","IE0008369823.USD","IE0008368742.USD","LU0315179316.USD","BK1515","LU0326950275.SGD","LU1152091754.HKD","LU1226288253.USD","LU1807302812.USD","BK1521","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","LU0140636845.USD","LU0314109678.HKD","LU1152091168.USD","LU0072913022.USD","BK1191","IE00B543WZ88.USD","LU1008478684.HKD","LU0501845795.SGD","LU1226287792.SGD","IE00B5MMRT66.SGD","LU0067412154.USD","LU1226287875.USD","LU0880133367.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663073709","title":"BYD Electronic (International) Stock Rises 9.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2663073709","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663073709?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:31","pubTimestamp":1788165060,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of BYD Electronic  Co. Ltd. rose 9.0% to 27.00 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.1% to 25566.99.This was the stock's fourth consecutive day of gains.BYD Electronic  Co. Ltd. closed 42% short of its 52-week high of HK$46.70, which the company achieved Sept. 2.The stock outperformed some of its competitors, as Times Universal Group Holdings Ltd. remained unchanged.Trading volume totaled 64.3 million shares, compared to the 50-day average of 11.4 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1580","LU0348767384.USD","BK1515","LU0348766576.USD","BK1167","BK1149","BK1582","BK1607","BK1540","BK1504","BK1589","LU0274383008.USD","00285"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102447356","title":"AH Share Premium Report: August 31 Market Close","url":"https://stock-news.laohu8.com/highlight/detail?id=1102447356","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102447356?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:21","pubTimestamp":1788164495,"startTime":"0","endTime":"0","summary":"As of the close on August 31, data shows NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and HOLLY FUTURES (03678) hold the top three positions in the A-H share premium ranking, with premium rates of...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00991","LU2279701549.SGD","LU1328277881.USD","LU1152091754.HKD","LU1303224171.USD","LU0648948544.HKD","SG9999001226.SGD","06185","IE00B031HY20.USD","BK1144","01349","LU0589944569.HKD","03308","BK1614","LU1282649810.SGD","02827","SG9999002828.SGD","LU1119993845.HKD","SG9999002463.SGD","06690","IE00B031J352.USD","BK1576","LU0791591158.USD","LU0449509016.USD","LU0163747925.USD","LU0417516738.SGD","LU0877626530.USD","LU0890818403.SGD","LU1242518857.USD","BK1533","LU2039709279.SGD","BK1526","BK1583","00187","LU1023057109.AUD","09981","LU0254981946.USD","00300","LU0149534421.HKD","BK1237","LU0359202008.SGD","LU2476274308.USD","LU0868486357.SGD","LU2048586759.USD","00981","BK1141","LU0244354667.USD","LU1282649141.HKD","BK1202","LU2294711473.HKD","IE0034224299.USD","02218","LU0307460666.USD","BK1594","BK1562","LU0205439572.USD","IE00BF5LJ272.USD","IE00BVYPNQ40.USD","LU0327786744.USD","LU1366334651.USD","SG9999011746.SGD","BK1505","LU0918141887.USD","00042","LU0370786039.SGD","LU1152091168.USD","03188","LU1211504680.USD","BK1506","LU1880383440.USD","399300","BK1147","LU0359201612.USD","LU0456846285.SGD","LU1008478684.HKD","03268","BK1507","LU1808992512.USD","LU0128522157.USD","01033","BK1223","01057","BK1560","LU2476274720.SGD","LU0607220059.USD","03200","LU1244550494.USD","03750","LU0072913022.USD","LU0516422952.EUR","LU1688375341.USD","LU0456827905.SGD","LU2394011477.USD","03130","LU0384037296.USD","LU2125910500.SGD","83188","LU0348827113.USD","BK1149","IE00B543WZ88.USD","LU0823426480.USD","BK1514","IE00B0169L03.USD","BK1171","LU0501845795.SGD","LU0672654166.SGD","LU0320764755.SGD","LU1244550577.SGD","BK1170","LU0348805143.USD","BK1161","LU1770034418.SGD","LU0561508036.HKD","LU1880383366.USD","LU2778985437.USD","03296","HK0001040168.HKD","LU0164880469.USD","159982","02691","00568","LU0228367735.SGD","LU0588546209.SGD","LU0543330566.HKD","LU0708995583.HKD","LU0543330483.HKD","BK1561","03678","LU0979878070.USD","LU1242518931.SGD","BK1123","LU1255011170.USD","LU0315179316.USD","LU1993786604.SGD","IE00BYV24P56.USD","LU0348766576.USD","LU0469268626.HKD","LU1282648689.USD","BK1231","LU2045819591.USD","LU0051755006.USD","LU1188198961.HKD","LU0737861699.HKD","LU1813983027.USD","LU2242644610.SGD","LU1831875114.USD","LU2399975544.HKD","BK1551","IE0031814852.USD","BK1249","LU0634319403.HKD","06869","LU0348814723.USD","LU1366334578.USD","LU1807302812.USD","LU0516423091.SGD","00317","LU0516423174.USD","LU0117841782.USD","LU0106959298.USD","LU1960683339.HKD","00753","02727","LU0880133367.SGD","LU0173614495.USD","LU0862451753.SGD","LU1251922891.USD","BK1607","IE0008369823.USD","LU0326950275.SGD","IE00BZ08YS42.EUR","LU0314109678.HKD","LU0540923850.HKD","BK1523","LU1244550221.USD","01877","LU0488056044.USD","BK1183","01108","HK0001040143.USD","LU0229945570.USD","02475","83130","82846","LU0531970944.HKD","IE00BPRC5H50.USD","HK0000352382.USD","BK1105","HK0000352291.HKD","BK1574","03968","BK1554","IE00BMCWC346.EUR","IE00BVYPNP33.GBP","IE00BZ08YT58.USD","LU0502904849.HKD","IE0008368742.USD","LU0516422440.USD","LU0287142896.SGD","00553","01812","LU1961090484.USD","LU0320764599.SGD","LU1720050803.USD","SG9999014674.SGD","LU1675838814.USD","IE00B5MMRT66.SGD","BK1191","LU2226246903.HKD","LU1655091616.SGD","LU0455707207.USD","01513","IE00B29SXG58.USD","LU0918141705.HKD","SG9999001093.SGD","LU1226287529.USD","LU0431992006.USD","LU1105468828.SGD","BK1557","LU0214875030.USD","BK1163","LU0823426308.USD","LU1046422090.SGD","02338","03986","LU0572944931.SGD","EWH","LU0417516902.SGD","LU0231483743.USD","BK1125","LU0348816934.USD","LU0593848301.USD","BK1515","LU0048580855.USD","LU1719994722.HKD","BK1522","LU1481107354.HKD","LU0640798160.USD","BK1116","LU0797268264.HKD","BK1214","IE00BGHQDM52.EUR","BK1205","IE00B3M56506.USD","IE00BZ08YR35.GBP","02359","BK1122","LU0067412154.USD","LU0210526637.USD","LU0149721374.USD","LU0463099449.HKD","LU0516422366.SGD","LU1794554557.SGD","SG9999006597.SGD","02846","LU1115378108.SGD","LU1224709979.USD","LU0348825331.USD","BK1521","LU0348788117.USD","BK1564","LU0029875118.USD","LU0052750758.USD","LU0348735423.USD","03143","BK1546","BK1610","LU0348767384.USD","LU0791590937.USD","LU1282649067.USD","07233","LU0359201885.HKD","03328","SG9999004220.SGD","BK1193","BK1530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663302408","title":"Ascletis Pharma Starts Phase III Trial of Weight-Loss Drug; Shares Plummet 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663302408","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663302408?lang=en_us&edition=fundamental","pubTime":"2026-08-31 13:22","pubTimestamp":1788153761,"startTime":"0","endTime":"0","summary":"Ascletis Pharma  said the first participant has been dosed in a global Phase III clinical program for ASC30, an oral drug being developed for long-term weight management and diabetes.The program comprises two late-stage trials involving about 4,600 participants across the U.S., Europe and Canada to assess the drug's effectiveness, safety and tolerability, according to a Sunday Hong Kong bourse filing.Shares of the company plunged over 5% in Monday's trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","BK1515","BK1574","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663446024","title":"CanSino Leads HK-Listed Vaccine Makers Lower as BioNTech Halts mRNA Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2663446024","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663446024?lang=en_us&edition=fundamental","pubTime":"2026-08-31 13:10","pubTimestamp":1788153044,"startTime":"0","endTime":"0","summary":"BUZZ-CanSino leads HK-listed vaccine makers lower as BioNTech halts mRNA trial** CanSino Biologics Hong Kong stock6185.HKleads slide in HK-listed shares of Chinese vaccine makers after news that BioNT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S04S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4585","06185","BK1574","BNTX","BK4568","BK4139","BK1515","BK4535","688185","BK1191","BK1161","BK4548","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663041570","title":"Ascletis Announces First Participant Dosed in a Global Phase Iii Clinical Program of Once-Daily Oral Small Molecule Glp-1 Receptor Agonist Asc30 for Chronic Weight Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2663041570","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663041570?lang=en_us&edition=fundamental","pubTime":"2026-08-30 18:15","pubTimestamp":1788084903,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260830:nTUAB84DSR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01672","BK1515","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663041506","title":"Ascletis Pharma - Topline Phase Iii Data Expected Q3 2028; FDA Nda by End 2028; Ema Maa Early 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2663041506","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663041506?lang=en_us&edition=fundamental","pubTime":"2026-08-30 18:15","pubTimestamp":1788084903,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260830:nTUAB84DSR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1515","BK1574","01672"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}